In my view, there was a lot of miscommunication floating around about LLBO expecting a response from the FDA about an approved 510K. What LLBO filed for was a review of their data to see how their machine would be classed if they submited a 510K. The PR reflected that LLBO was going to file the 510K as the next step and it was not what people were expecting so the stock took an immediate nose dive due to disappointment. Hopefully it will create a better entry point me as I still need to buy. I think LLBO is one year out from commercialization. If they file the 510K this month, we are looking at late summer for a response. Good luck to you.



LinkBack URL
About LinkBacks
Reply With Quote
